AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2 : Preclinical Data on Therapeutic Time Window and Long-Term Effects

Tanimoto, Naoyuki; Sothilingam, Vithiyanjali; Garrido, Marina Garcia; Beck, Susanne C.; Huber, Gesine; Biel, Martin; Seeliger, Mathias W.; Michalakis, Stylianos; Mühlfriedel, Regine; Schön, Christian

dc.contributor.author	Tanimoto, Naoyuki
dc.contributor.author	Sothilingam, Vithiyanjali
dc.contributor.author	Garcia Garrido, Marina
dc.contributor.author	Beck, Susanne C.
dc.contributor.author	Huber, Gesine
dc.contributor.author	Mühlfriedel, Regine
dc.contributor.author	Seeliger, Wolfgang Mathias
dc.date.accessioned	2019-05-28T08:27:37Z
dc.date.available	2019-05-28T08:27:37Z
dc.date.issued	2017
dc.identifier.issn	1662-453X
dc.identifier.uri	http://hdl.handle.net/10900/88976
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fnins.2017.00292	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2 : Preclinical Data on Therapeutic Time Window and Long-Term Effects	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_02682
utue.personen.roh	Tanimoto, Naoyuki
utue.personen.roh	Sothilingam, Vithiyanjali
utue.personen.roh	Garrido, Marina Garcia
utue.personen.roh	Beck, Susanne C.
utue.personen.roh	Huber, Gesine
utue.personen.roh	Biel, Martin
utue.personen.roh	Seeliger, Mathias W.
utue.personen.roh	Michalakis, Stylianos
utue.personen.roh	Mühlfriedel, Regine
utue.personen.roh	Schön, Christian
dcterms.isPartOf.ZSTitelID	Frontiers in Neuroscience	de_DE
dcterms.isPartOf.ZS-Issue	Article 292	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE